??, page-4

Danizinoz,

I could be wrong but I'm pretty sure the terms of the last CR expired last month. i.e. IMO it'll be a new CR but am guessing at a similar strike price (@7c) and to be offered to instos and/or high net worth investors only.

All speculation on my behalf but if you've read my last post re: my interpretation of a conversation, the "you got it" response from SP may mean proceeds from adit material could be factored into the revenue mix in the not too distant future.

Again just me trying to put myself in SP's shoes, but he could be thinking that if we can get away with limiting finance to another CR until the ML stage, then with the discovery of additional high grade ozs (as planned) that could provide the company with ultimate leverage to finalise the best possible debt funding terms as we gear up towards production. Add to that the potential early cashflow benefits from the adit material and I see happy times ahead.

Therefore I'm not concerned about this CR unless it is a very large raise at a discounted strike price eg. say 300+ million shares at 6c or less, which would then mean consequential dilution for shareholders.

The bigger picture however is that (hopefully) now we at least have the funds required to proceed with the accelerated development of the adit, and such a scenario should be treated as VERY good news for investors IMO.

Cheers
Elpha

Note: my opinion is mine only and in no way am I offering advice of any kind. Please DYOR.